Surgalign Financial Statements From 2010 to 2024

SRGADelisted Stock  USD 0.04  0  12.54%   
Surgalign Holdings financial statements provide useful quarterly and yearly information to potential Surgalign Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Surgalign Holdings financial statements helps investors assess Surgalign Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Surgalign Holdings' valuation are summarized below:
Surgalign Holdings does not presently have any fundamental trend indicators for analysis.
Check Surgalign Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgalign Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Surgalign financial statements analysis is a perfect complement when working with Surgalign Holdings Valuation or Volatility modules.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Surgalign Holdings Company Return On Equity Analysis

Surgalign Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Surgalign Holdings Return On Equity

    
  -14.97  
Most of Surgalign Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgalign Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Surgalign Holdings has a Return On Equity of -14.9702. This is 37.55% lower than that of the Health Care Equipment & Supplies sector and 71.48% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Surgalign Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Surgalign Holdings's current stock value. Our valuation model uses many indicators to compare Surgalign Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgalign Holdings competition to find correlations between indicators driving Surgalign Holdings's intrinsic value. More Info.
Surgalign Holdings is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgalign Holdings' earnings, one of the primary drivers of an investment's value.

About Surgalign Holdings Financial Statements

Surgalign Holdings stakeholders use historical fundamental indicators, such as Surgalign Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Surgalign Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in Surgalign Holdings' assets and liabilities are reflected in the revenues and expenses on Surgalign Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Surgalign Holdings. Please read more on our technical analysis and fundamental analysis pages.
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Surgalign Stock

If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data